179 related articles for article (PubMed ID: 20824434)
1. [DNA methylation. From basic research to routine diagnostics].
Lehmann U
Pathologe; 2010 Oct; 31 Suppl 2():274-9. PubMed ID: 20824434
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
[TBL] [Abstract][Full Text] [Related]
5. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
6. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
8. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
[TBL] [Abstract][Full Text] [Related]
10. Mutator pathways unleashed by epigenetic silencing in human cancer.
Jacinto FV; Esteller M
Mutagenesis; 2007 Jul; 22(4):247-53. PubMed ID: 17412712
[TBL] [Abstract][Full Text] [Related]
11. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
[TBL] [Abstract][Full Text] [Related]
14. [Methylation pattern of DNA repair genes and microsatellite instability in hepatocelluar carcinoma].
Park JH; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Lee JH; Kim SJ
Korean J Gastroenterol; 2006 Nov; 48(5):327-36. PubMed ID: 17132921
[TBL] [Abstract][Full Text] [Related]
15. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.
Michailidi C; Theocharis S; Tsourouflis G; Pletsa V; Kouraklis G; Patsouris E; Papavassiliou AG; Troungos C
Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636
[TBL] [Abstract][Full Text] [Related]
16. A study of the frequency of methylation of gene promoter regions in colorectal cancer in the Taiwanese population.
Wu CC; Kuan JC; Hsu CH; Chen TA; Sun CA; Yang T; Lin SL; Chou YC
J Genet; 2013 Apr; 92(1):109-13. PubMed ID: 23640413
[No Abstract] [Full Text] [Related]
17. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
Kupčinskaitė-Noreikienė R; Skiecevičienė J; Jonaitis L; Ugenskienė R; Kupčinskas J; Markelis R; Baltrėnas V; Sakavičius L; Semakina I; Grižas S; Juozaitytė E
Medicina (Kaunas); 2013; 49(8):361-6. PubMed ID: 24509146
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
Ali AH; Kondo K; Namura T; Senba Y; Takizawa H; Nakagawa Y; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Mol Carcinog; 2011 Feb; 50(2):89-99. PubMed ID: 21229606
[TBL] [Abstract][Full Text] [Related]
19. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells].
Meng CF; Zhu XJ; Dai DQ; Peng G
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343
[TBL] [Abstract][Full Text] [Related]
20. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas.
Judson H; Stewart A; Leslie A; Pratt NR; Baty DU; Steele RJ; Carey FA
J Pathol; 2006 Nov; 210(3):344-50. PubMed ID: 16902913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
